Ⅰ期至Ⅲ_A期肺癌外科规范化治疗的研究进展  

Research Progress of Standardized Surgery for Stage Ⅰ to Ⅲ_A Lung Cancer

作　　者：王珏[1] 郭占领[1] 

机构地区：[1]哈励逊国际和平医院胸外科,河北衡水053000

出　　处：《中国胸心血管外科临床杂志》2014年第5期675-680,共6页Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

摘　　要：原发性肺癌发生于支气管黏膜上皮,亦称支气管肺癌,目前已经成为我国恶性肿瘤的首位死亡原因。尽管在我国医师不断努力下,肺癌的诊治取得了一定的进展,但由于地域差异、医疗单位性质的差异以及各地技术水平的差异,肺癌外科治疗的规范化仍然存在着较大的差别。完整规范的手术切除可以为Ⅰ期、Ⅱ期及部分ⅢA期肺癌患者提供良好的长期生存结果,这是其他治疗所不能替代的,由此可见外科规范化治疗的重要性。作为肺癌多学科治疗中最坚实的一员,外科手术的质量决定着肺癌多学科综合治疗的疗效,时代的发展要求我们胸外科医师按照循证医学的证据为患者提供最规范化、个体化的治疗方案。现对Ⅰ期至部分ⅢA期肺癌外科规范化治疗的进展进行综述。Primary bronchopulmonary carcinoma occurs in the bronchial mucosa epithelium, also called lung cancer （LC）, and has currently become the first cause of death of malignant tumors in China. With constant efforts of Chinese physicians, the diagnosis and management of LC has made certain progress, but standardized surgery for LC still varies to a great extent due to difference regions, nature of medical centers, and technical levels. Complete and standardized surgical resection can provide good long-term survival for patients with stage I, II and partly Ⅲ LC, and cannot be a substitute for other treatment, which shows the importance of standardized surgery. As the most solid member, surgery plays a decisive role in comprehensive multidisciplinary treatment of LC. Today＇s medical development requires thoracic surgeons to provide most standardized and individualized treatment with principles of evidence-based medicine. This review focuses on progress of standardized surgery for stage Ⅰ to ⅢA LC.

关 键 词：肺癌 外科治疗 规范化 

分 类 号：R734.2[医药卫生—肿瘤]